Venture_Socks_RZ_RGB_300dpi(2)_edited.pn
icon-prizes.png

WINNERS

orange arrows.png

FunZyme BioTechnologies S.A.

2006

Health & Nutrition

2000_W1_Carbofix.png
Sensirion_edited.jpg

FunZyme BioTechnologies will develop and commercialize new enzyme-based drugs and agents for some important applications in health care and biotechnology. It will do so by exploiting potent enzymes isolated from fungi that have the property to cleave any protein from its extremities resulting in the release of single amino acids. The company was liquidated in 2019.